Media headlines about Edap Tms (NASDAQ:EDAP) have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Edap Tms earned a media sentiment score of 0.22 on Accern’s scale. Accern also gave headlines about the medical equipment provider an impact score of 45.7932465480022 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

EDAP has been the subject of a number of research analyst reports. Zacks Investment Research lowered Edap Tms from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 29th. HC Wainwright reaffirmed a “buy” rating and issued a $6.50 price target on shares of Edap Tms in a research note on Friday, August 25th. Finally, ValuEngine raised Edap Tms from a “sell” rating to a “hold” rating in a research note on Friday, October 6th.

Edap Tms (NASDAQ:EDAP) opened at $2.86 on Friday. The company has a quick ratio of 2.35, a current ratio of 2.96 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $83.16, a price-to-earnings ratio of 95.60 and a beta of 1.00. Edap Tms has a twelve month low of $2.25 and a twelve month high of $3.85.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Wednesday, November 15th. The medical equipment provider reported ($0.02) earnings per share for the quarter, meeting the consensus estimate of ($0.02). Edap Tms had a positive return on equity of 5.89% and a negative net margin of 5.36%. The firm had revenue of $8.44 million during the quarter, compared to the consensus estimate of $11.05 million. Edap Tms’s revenue was down 5.6% compared to the same quarter last year. equities analysts forecast that Edap Tms will post -0.01 EPS for the current year.

WARNING: “Edap Tms (EDAP) Earning Somewhat Favorable Media Coverage, Study Shows” was originally published by Watch List News and is the property of of Watch List News. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at

Edap Tms Company Profile

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

Insider Buying and Selling by Quarter for Edap Tms (NASDAQ:EDAP)

Receive News & Ratings for Edap Tms S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms S.A. and related companies with Analyst Ratings Network's FREE daily email newsletter.